Hill 45 InvestorsObserver gives shares of Recursion Pharmaceuticals Inc (RXRX) puts it near the middle of the biotech industry. In addition to scoring more than 46% of biotech stocks, RXRX’s overall rating of 45 means the stock scores better than 45% of all stocks.
What do these notes mean?
Stock analysis can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We categorize most of our scores by percentiles to make it easier for investors to understand. A score of 45 means the stock is more attractive than 45% of the stock. Our proprietary rating system captures technical factors, fundamental analysis and the opinions of Wall Street analysts. This makes InvestorsObserverThe overall rating of is a great way to get started, regardless of your investing style. Scores ranked in percentiles are also easy to understand. A score of 100 is high and a 0 is low. There’s no need to try to remember what’s “good” for a bunch of complicated ratios, just pay attention to the higher numbers.
What’s going on with Recursion Pharmaceuticals Inc stock today?
Recursion Pharmaceuticals Inc (RXRX) stock is trading at $8.10 at 2:57 p.m. on Wednesday, January 25, down -$0.49, or -5.7% from the previous closing price of 8 $.59. The stock has traded between $7.74 and $8.43 so far today. The volume today is light. So far, 544,685 shares have been traded with an average volume of 1,309,017 shares. Click here for the full Recursion Pharmaceuticals Inc. stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.